Log in here
Top Journalists
>
Charles Bankhead

Charles Bankhead

Senior Editor at MedPage Today

Contact this person
Email address
c*****@*******.comGet email address
Influence score
53
Phone
(XXX) XXX-XXXXGet mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

medpagetoday.com

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1
23 days ago
medpagetoday.com

Remote-Controlled Urinary Sphincter Could Transform Incontinence Tr...

In limited testing, device gets high marks for urinary control, elimination of awkwardness
26 days ago
medpagetoday.com

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study
about 1 month ago
medpagetoday.com

No Survival Bump in Metastatic NSCLC With Addition of ADC to Immuno...

Non-significant 4-month PFS increase with sacituzumab govitecan-pembrolizumab, no OS benefit
about 1 month ago
medpagetoday.com

Loss of Follow-Up Predictors in Wet AMD

Travel distance, race/ethnicity, male sex boost odds, may inform adherence strategies
about 1 month ago
medpagetoday.com

Cancer Diagnosis, Then a Stroke; 9/11 Cancer Deaths; 'Grand Slam' D...

News, features, and commentary about cancer-related issues
about 1 month ago
medpagetoday.com

Organ Preservation vs Immediate Surgery for Esophageal Adenocarcinoma

Despite issues, active surveillance has potential, and surgery has evolved from bad reputation
about 1 month ago
medpagetoday.com

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phas...

News, features, and commentary about cancer-related issues
about 1 month ago
medpagetoday.com

Dolly's Cancer Death; Mammogram Safety Alert; Chemo Drug Shortage W...

News, features, and commentary about cancer-related issues
about 2 months ago
medpagetoday.com

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial
about 2 months ago
medpagetoday.com

Risk of Pancreatic Cysts Becoming Cancer Grows as Worrisome Traits ...

2% risk with one worrisome or high-risk feature, but risk rises to 18% with three or more traits
about 2 months ago